Fangtian Bu

906 total citations
31 papers, 722 citations indexed

About

Fangtian Bu is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Fangtian Bu has authored 31 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Hepatology and 11 papers in Epidemiology. Recurrent topics in Fangtian Bu's work include Liver physiology and pathology (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and MicroRNA in disease regulation (8 papers). Fangtian Bu is often cited by papers focused on Liver physiology and pathology (12 papers), Liver Disease Diagnosis and Treatment (11 papers) and MicroRNA in disease regulation (8 papers). Fangtian Bu collaborates with scholars based in China, Singapore and Madagascar. Fangtian Bu's co-authors include Jun Li, Xiao‐Ming Meng, Cheng Huang, Cheng Huang, Xue‐Yin Pan, Haixia Yu, Hongmei You, Sai Zhu, Hai-Di Li and Ao Wang and has published in prestigious journals such as The FASEB Journal, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Fangtian Bu

27 papers receiving 713 citations

Peers

Countries citing papers authored by Fangtian Bu

Since Specialization

Citations

This map shows the geographic impact of Fangtian Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangtian Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangtian Bu more than expected).

Fields of papers citing papers by Fangtian Bu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangtian Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangtian Bu. The network helps show where Fangtian Bu may publish in the future.

Co-authorship network of co-authors of Fangtian Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangtian Bu. A scholar is included among the top collaborators of Fangtian Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangtian Bu. Fangtian Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	N6 ‐Methyladenosine‐Modified circNEK11 Promotes Hepatocellular Carcinoma Progression via the miR ‐1236‐3p/ GPX2 Axis 2025 ·Cancer Science ·Qian Li, (unknown), Yan Tong, (unknown), (unknown), Cunjie Chang, Heng Dong, Fangtian Bu, Shuanghong Yan, (unknown), Jianxiang Chen	0
2	Redistribution of super-enhancers promotes malignancy in human hepatocellular carcinoma 2025 ·Journal of Advanced Research ·J. S. Huang, Liang Xu, Ye Chen, (unknown), Yiqing Hu, Caixu Pan, Liangyu Jiang, (unknown), Jing Liu, (unknown), Qian Li, Fangtian Bu, Cunjie Chang, Xuliang Chen, Yu Wang, Shusen Zheng, Qi Ling, Jianxiang Chen, Yiting Qiao	0
3	The interplay between post-transcriptional RNA regulation and Wnt/β-Catenin signaling in cancer: A Review 2025 ·International Journal of Biological Macromolecules ·(unknown), (unknown), (unknown), Lina Li, Minjie Wu, Qian Li, Fangtian Bu, Heng Dong, Jianwei Han, Ying Jie, Jianxiang Chen	2
4	The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases 2024 ·Theranostics ·Fangtian Bu, Haiyan Wang, Chao‐Nan Xu, (unknown), (unknown), (unknown), (unknown), Jianxiang Chen	6
5	Kinesin family member 18B activates mTORC1 signaling via actin gamma 1 to promote the recurrence of human hepatocellular carcinoma 2023 ·Oncogenesis ·Qian Li, (unknown), Meng Yao, (unknown), (unknown), Cunjie Chang, Heng Dong, Fangtian Bu, (unknown), Jing Liu, Qi Ling, Yiting Qiao, Jianxiang Chen	5
6	Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases 2022 ·Cells ·Hongmei You, Ling Wang, Fangtian Bu, (unknown), Cheng Huang, (unknown), Jun Li	21
7	Emerging therapeutic potential of adeno-associated virus-mediated gene therapy in liver fibrosis 2022 ·Molecular Therapy — Methods & Clinical Development ·Fangtian Bu, (unknown), Yan Zhu, Yaru Yang, (unknown), Yihui Bi, Cheng Huang, Jun Li	10
8	The miR‐455‐3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics 2021 ·The FASEB Journal ·Hongmei You, Ling Wang, Fangtian Bu, (unknown), Xue‐Yin Pan, Juanjuan Li, Yafei Zhang, Ao Wang, (unknown), Cheng Zhi Huang, Jun Li	11
9	Hesperetin derivative-16 attenuates CCl4-induced inflammation and liver fibrosis by activating AMPK/SIRT3 pathway 2021 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Ao Wang, Fangtian Bu, (unknown), Sai Zhu, Lin Zhu, Cheng Huang, Jun Li	37
10	Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis 2021 ·Molecular Therapy — Nucleic Acids ·Fangtian Bu, Yan Zhu, Xin Chen, Ao Wang, Yafei Zhang, Hongmei You, Yang Yang, Yaru Yang, Cheng Huang, Jun Li	30
11	MicroRNA-195-3p promotes hepatic stellate cell activation and liver fibrosis by suppressing PTEN expression 2021 ·Toxicology Letters ·Ao Wang, Fangtian Bu, Juanjuan Li, Yafei Zhang, (unknown), Hongmei You, Sha Wu, Yuanyuan Wu, Sai Zhu, Cheng Zhi Huang, Jun Li	17
12	O-alkyl and o-benzyl hesperetin derivative-1L attenuates inflammation and protects against alcoholic liver injury via inhibition of BRD2-NF-κB signaling pathway 2021 ·Toxicology ·Juanjuan Li, Xinyi Lü, (unknown), Lin Zhu, Ao Wang, Fangtian Bu, Yilong Zhang, Cheng Huang, Jun Li	13
13	PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β‐catenin signalling pathway 2020 ·Journal of Cellular and Molecular Medicine ·Yu Chen, Xin Chen, (unknown), Sai Zhu, Fangtian Bu, (unknown), Xiao‐Ming Meng, Cheng Huang, (unknown)	33
14	Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis 2020 ·Theranostics ·Xin Chen, Hai-Di Li, Fangtian Bu, Xiaofeng Li, Yu Chen, Sai Zhu, Jianan Wang, (unknown), Ying-Yin Sun, Xue‐Yin Pan, (unknown), Jiejie Xu, Cheng Huang, Jun Li	68
15	LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway 2020 ·Molecular Immunology ·Yaru Yang, Fangtian Bu, Yang Yang, Hao Li, Cheng Huang, Xiao‐Ming Meng, Lei Zhang, Xiongwen Lv, Jun Li	22
16	Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells 2019 ·Molecular Immunology ·Haixia Yu, Yao Yao, Fangtian Bu, Yu Chen, Yuting Wu, Yang Yang, Xin Chen, Yan Zhu, Qin Wang, Xue‐Yin Pan, Xiao‐Ming Meng, Cheng Huang, Jun Li	77
17	The Long Non-coding RNA MEG3/miR-let-7c-5p Axis Regulates Ethanol-Induced Hepatic Steatosis and Apoptosis by Targeting NLRC5 2018 ·Frontiers in Pharmacology ·Qin Wang, Mingfang Li, Zhiming Shen, Fangtian Bu, Haixia Yu, Xue‐Yin Pan, Yang Yang, Xiao‐Ming Meng, Cheng Huang, Jun Li	33
18	SENP2 alleviates CCl4-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion 2018 ·Toxicology Letters ·Fangtian Bu, Yu Chen, Haixia Yu, Xin Chen, Yang Yang, Xue‐Yin Pan, Qin Wang, Yuting Wu, Cheng Huang, Xiao‐Ming Meng, Jun Li	24
19	DNA Methylation of PTGIS Enhances Hepatic Stellate Cells Activation and Liver Fibrogenesis 2018 ·Frontiers in Pharmacology ·Xue‐Yin Pan, Yang Yang, (unknown), Hai-Di Li, Xin Chen, Huimin Huang, Fangtian Bu, Haixia Yu, Qin Wang, Cheng Huang, Xiao‐Ming Meng, Jun Li	27
20	Methylation of Septin9 mediated by DNMT3a enhances hepatic stellate cells activation and liver fibrogenesis 2016 ·Toxicology and Applied Pharmacology ·Yuting Wu, Fangtian Bu, Haixia Yu, Wanxia Li, Cheng Huang, Xiao‐Ming Meng, Lei Zhang, Taotao Ma, Jun Li	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact